drug development

Washington, D.C., September 20, 2026 The Heart Failure Society of America (HFSA) has announced the late-breaking clinical research program...

New York, United States, September 20, 2026 Accro Bioscience has announced that the first patient has been dosed in...

Sarasota, Florida, September 18, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced that it has received central and all clinical-site Institutional...

VANCOUVER, Canada — September 17, 2026 Clearmind Medicine announced that its Chief of Global Impact, Mary-Elizabeth Gifford, testified at...

MIAMI, Fla. — September 17, 2026 Telomir Pharmaceuticals announced the peer-reviewed publication of new preclinical research showing that Telomir-Zn...

LIBERTY CORNER, N.J. — September 17, 2026 Lisata Therapeutics announced the acquisition of Marea Therapeutics, combining the companies to...

MIAMI, Fla. — September 17, 2026 MIRA Pharmaceuticals announced that its Phase 2a protocol for Ketamir-2 in chemotherapy-induced peripheral...

LONDON and PHILADELPHIA — September 16, 2026 Avacta Therapeutics announced clinical proof of mechanism for AVA6103, its next-generation controlled-release...

Yongin, South Korea, September 17, 2026 1ST Biotherapeutics, Inc. (1STBIO) and SK Biopharmaceuticals Co., Ltd. (SKBP) have announced an...

Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...